Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
233 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 3 (1%) | |
| Resolved: | 223 (96%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 2 (7%) | |
| Discontinued: | 27 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
14 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PROPOFOL | 10MG | EMULSION | Resolved | 2019-05-15 | 2019-06-07 | 84202 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2019-07-29 | 2019-08-27 | 90084 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2020-01-17 | 2020-02-12 | 103474 |
| PROPOFOL | 10MG | EMULSION | Resolved | 2020-03-24 | 2020-04-25 | 109301 |
| PROPOFOL INJECTION | 10MG | EMULSION | Avoided shortage | 2023-11-17 | 2024-05-03 | 210580 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2023-11-17 | 2024-01-10 | 210583 |
| PROPOFOL INJECTION | 10MG | EMULSION | Avoided shortage | 2023-11-17 | 2024-05-03 | 210586 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2024-04-19 | 2024-05-03 | 225667 |
| PROPOFOL INJECTION | 10MG | EMULSION | Resolved | 2024-08-15 | 2024-08-24 | 235264 |
| SEVOFLURANE | 99.97% | LIQUID | Resolved | 2021-12-13 | 2022-01-20 | 151068 |
| SEVOFLURANE | 99.97% | LIQUID | Resolved | 2024-06-13 | 2024-07-03 | 230374 |
| SEVOFLURANE | 99.97% | LIQUID | Resolved | 2024-09-06 | 2024-10-23 | 236909 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-08-15 | 2018-03-01 | 19378 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-10-17 | 2018-11-27 | 26121 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2017-12-08 | 2018-11-27 | 32177 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56915 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56918 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2018-12-05 | 2019-02-26 | 68703 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2019-02-15 | 2019-04-11 | 76013 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | LIQUID | Resolved | 2019-02-15 | 2019-03-01 | 76018 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| CLINOLEIC 20% | 4% 16% | EMULSION | Discontinued | 2017-04-04 | 2018-01-01 | 5289 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
| PROCYTOX | 200MG | POWDER FOR SOLUTION | To be discontinued | 2025-08-14 | 2025-08-14 | 265253 |
| PROCYTOX TAB 25MG | 25MG | TABLET | To be discontinued | 2025-08-14 | 2025-08-14 | 265250 |